Samera S.A.
Monitoring Tuberculous infection & inoculation services.
AI Overview
With $0 in lobbying spend across 18 quarterly filings, Samera S.A is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Samera S.A. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED
Monitoring Tuberculous Infection/Vaccination in Paraguay and U.S.-affiliated Pacific islands
Requesting NIH Grant Funding
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.